A phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in muscle invasive bladder cancer (ABACUS).

被引：30
|
作者：
Powles, Thomas
Rodriguez-Vida, Alejo
Duran, Ignacio
Crabb, Simon J.
Van der Heijden, Michiel Simon
Pous, Albert Font
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.4506
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4506
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Neoadjuvant Phase II Studies of Modified Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Cancer Reply
    Plimack, Elizabeth R.
    Hoffman-Censits, Jean
    Rosenberg, Jonathan E.
    Wong, Yu-Ning
    Bellmunt, Joaquim
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (36) : 4171 - U408
  • [42] Safety of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer and malignant ureteric obstruction
    Strother, Marshall C.
    Kutikov, Alexander
    Epstein, Matthew
    Bochner, Emily
    Deng, Mengying
    Handorf, Elizabeth
    Lewis, Bianca
    Ghatalia, Pooja
    Greenberg, Richard E.
    Chen, David
    Viterbo, Rosalia
    Anari, Fern
    Smaldone, Marc C.
    Zibelman, Matthew R.
    Uzzo, Robert G.
    Plimack, Elizabeth R.
    Geynisman, Daniel M.
    BJU INTERNATIONAL, 2022, 129 (03) : 364 - 372
  • [43] Neoadjuvant chemotherapy in muscle invasive bladder cancer: Real world data on safety and outcome.
    Panthula, Sree Vamsee Chetana
    Philip, Arun
    Keechilat, Pavithran
    Jose, Wesley Mannirathil
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [44] Association of Molecular Subtypes with Pathologic Response, PFS, and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
    Lerner, Seth P.
    Mcconkey, David J.
    Tangen, Catherine M.
    Meeks, Joshua J.
    Flaig, Thomas W.
    Hua, Xing
    Daneshmand, Siamak
    Alva, Ajjai Shivaram
    Lucia, M. Scott
    Theodorescu, Dan
    Goldkorn, Amir
    Milowsky, Matthew I.
    Choi, Woonyoung
    Bangs, Rick
    Gustafson, Daniel L.
    Plets, Melissa
    Thompson Jr, Ian M.
    CLINICAL CANCER RESEARCH, 2024, 30 (02) : 444 - 449
  • [45] Phase II randomised placebo controlled neoadjuvant chemotherapy study of nintedanib with gemcitabine and cisplatin in locally advanced muscle invasive bladder cancer.
    Hussain, Syed A.
    Jackson, Richard
    Shields, Alice
    Dickinson, Lynne
    Cornford, Philip
    Jones, Robert J.
    Lester, Jason Francis
    Chester, John D.
    Birtle, Alison J.
    Powles, Thomas
    Crabb, Simon J.
    Mazhar, Danish
    Huddart, Robert Anthony
    Protheroe, Andrew
    Azam, Faisal
    Vasudev, Naveen
    Butt, Mohammad
    James, Nicholas David
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [46] Single-arm phase I/II study of the safety and efficacy of OncoTherad immunomodulator in patients BCGrefractory or relapsed non-muscle invasive bladder cancer.
    Favaro, Wagner Jose
    Iantas, Sonia Regina
    Goncalves, Juliana Mattoso
    Rabelo Socca, Eduardo Augusto
    Duran, Nelson
    Billis, Athanase
    Cardoso Alonso, Joao Carlos
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [47] Neoadjuvant chemotherapy and chemoradiotherapy with gemcitabine in muscle invasive bladder cancer
    Thompson, C.
    Anandadas, C.
    Stratford, J.
    Lyons, J.
    Elliott, P.
    Livsey, J.
    Logue, J.
    Wylie, J.
    Cowan, R.
    Choudhury, A.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S85 - S85
  • [48] Immune Responses to Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer
    Sherif, Amir
    Winerdal, Malin
    Winqvist, Ola
    BLADDER CANCER, 2018, 4 (01) : 1 - 7
  • [49] Risk based neoadjuvant chemotherapy in muscle invasive bladder cancer
    Jayaratna, Isuru S.
    Navai, Neema
    Dinney, Colin P. N.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2015, 4 (03) : 273 - 282
  • [50] Neoadjuvant and Adjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
    Calabro, Fabio
    Sternberg, Cora N.
    EUROPEAN UROLOGY, 2009, 55 (02) : 348 - 358
12345